Cotinine Screening Devices Market Size, Share, Competition Landscape, Manufacturers Analysis and Future Opportunity Outlook 2029 | Says FMI Analyst

Smoking is one of the most hazardous causes leading to various chronic illnesses, worldwide. According to the American Lung Association, smoking is responsible for 1 in 5 deaths in the US, annually. Cotinine is a metabolite of nicotine and is a type of alkaloid that is found in tobacco. It is toxic that produces stimulation of the central nervous system and autonomic ganglia in humans. After the body metabolizes nicotine post-ingestion, cotinine is produced. It is also used as a biomarker for exposure to tobacco. Cotinine is typically detectable for approximately 2 days after the use of tobacco and thus, have an in vivo half-life of almost 20 hours. Cotinine screening devices are devices used for screening presence of cotinine in the body.

Cotinine screening devices measure or detect the presence of cotinine or nicotine in urine, blood, saliva or at times in the hair. Different cotinine screening devices are available in the market that are used for testing a person’s smoking status. 

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-8472

Cotinine Screening Devices Market: Drivers and Restraints-

Constant technological advancements in cotinine screening devices is highly responsible for driving the market for cotinine screening devices. Growing awareness on cotinine screening devices and government support for anti-smoking campaigns is also expected to drive the market for cotinine screening devices during the forecast period. Cotinine screenings are also being incorporated for wellness and several institutions and organizations test for cotinine prior interviews or admissions. Increasing awareness on side-effects of smoking has led to a smoking cessation environment, globally. Cotinine screening devices are used to track a person’s smoking status. This is also anticipated to boost the market growth for cotinine screening devices market during the forecast period. However, low product penetration across regions and several false-positive limitations are expected to hinder the market growth for cotinine screening devices over the forecast period.

Cotinine Screening Devices Market: Segmentation

Tentatively, Cotinine Screening Devices Market has been segmented on the basis of Test type, Detection type, end users and geography.

On the basis of product type, Cotinine Screening Devices Market can be segmented as:

• Blood Tests
• Urine Tests
• Saliva Tests
• Hair Tests

On the basis of detection type, Cotinine Screening Devices Market can be segmented as:

• Qualitative Detection
• Quantitative Detection

On the basis of end users, Cotinine Screening Devices Market can be segmented as:

• Hospitals
• Laboratories
• Rehabilitation Centers
• Clinics
• Others

On the basis of geography, Cotinine Screening Devices Market can be segmented as:

• North- America
• Eastern Europe
• Western Europe
• Asia-Pacific excluding China & Japan
• China
• Japan
• Middle East and Africa
• Latin America

Cotinine Screening Devices Market: Overview

Global Cotinine Screening Devices market is expected to grow significantly owing it to the increasing unhealthy lifestyle, globally. Employee screening and wellness programs are being incorporated worldwide. Cotinine screening devices are being extensively used for testing for tobacco use and even to analyze smoking patterns. People going through smoking cessations are often tested for cotinine. Cotinine screening devices for blood testing have evolved from taking days to quantitatively detecting cotinine within minutes. Cotinine screening devices for hair testing are expensive and require professional laboratory equipment. These tests are not rapid and take days. Saliva testing for cotinine involve swab cotinine screening devices. Cotinine screening devices available in the market can quantitatively as well as qualitatively detect cotinine content in the body. All cotinine screening devices, except the hair testing devices, are used for employee screening and wellness programs.

Cotinine Screening Devices Market: Region-wise Outlook

Geography wise, Cotinine Screening Devices market is divided into eight regions viz. North-America, Asia- Pacific excluding China & Japan, China, Japan, Western Europe, Eastern Europe, Latin America and Middle-East & Africa. North America’s Cotinine Screening Devices market is expanding because of growing product penetration and adoption rate and it will remain dominant over the period of forecast due to high number of healthcare facilities and expenditure. Rapid increase in smoking cases also contributes to the share in the region. Europe’s Cotinine Screening Devices market is also expected to grow at a significant rate due to improved availability and affordability in the product range of Cotinine Screening Devices. Asia-Pacific’s Cotinine Screening Devices market is anticipated to grow at a moderate rate due to poor awareness about Cotinine Screening Devices and low healthcare expenditure.

Cotinine Screening Devices Market: Key Market Participants

Some of the market participants in the Global Cotinine Screening Devices market identified across the value chain include: Alere, AlcoPro, Jant Pharmacal Corporation,PTS Diagnostics, Mossman Associates, Nano-Ditech Corp, LifeSign LLC, ALFA Scientific, and Ameritek USA.

The research report on cotinine screening devices present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The cotinine screening devices report provides analysis and information according to market segments such as geographies, application, and industry.

Request for Report Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-8472

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico. Brazil)
• Western Europe (Germany, Italy, France, U.K, Spain)
• Eastern Europe (Poland, Russia)
• Asia Pacific (India, ASEAN, Australia & New Zealand)
• China
• Japan
• Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Respiratory Inhaler Devices Market – A slew of new drugs were launched for the management of asthma and COPD over the last decade and development of more are currently underway. With leading drug manufacturers expecting the demand to surge amid COVID-19, respiratory inhaler sales are set to grow steadily through 2030.

Microbial Therapeutic Products Market – The global microbial therapeutic products market is poised to expand robustly at a value CAGR worth 7% across the 2020-2030 assessment period. Rising prevalence of lifestyle induced chronic disorders as well as antimicrobial resistance are primarily driving the market’s growth.

Transradial Closure Devices Market – According to Future Market Insights (FMI), the demand from hospitals, independent catheterization centers, and healthcare clinics will continue rising. Spurred by this, the global transradial closure devices market is set to grow by 6.5% CAGR during the forecast period from the year 2020 to 2030.

About FMI       

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us                                        

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com